Camp4 Therapeutics Corporation (CAMP)

Camp4 Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Oct 2, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Market Capitalization	60	105	-	-
Enterprise Value	28	274	-	-
Last Close Price	2.98	5.22	-	-
PS Ratio	14.40	161.17	-	-
PB Ratio	1.50	1.66	-	-
P/TBV Ratio	1.50	1.66	-	-
EV/Sales Ratio	9.39	420.77	-	-
Debt / Equity Ratio	0.18	0.14	0.32	0.15
Asset Turnover	0.07	0.01	0.00	-
Quick Ratio	5.34	6.68	4.97	10.56
Current Ratio	5.60	6.92	5.13	10.62
Return on Equity (ROE)	-188.23%	-101.99%	-80.13%	-
Return on Assets (ROA)	-82.61%	-49.80%	-41.17%	-
Return on Capital (ROIC)	-92.22%	-54.18%	-43.93%	-
Earnings Yield	-86.19%	-49.29%	-	-
FCF Yield	-76.82%	-43.78%	-	-
Buyback Yield / Dilution	-3161.44%	-1087.44%	-26.47%	-

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q